SOX9 knockdown in IPF fibroblasts resulted in a significant increase in TUNEL-positive fibroblasts with the treatment of anti-Fas antibody compared with control antibody (Figure 4, G and H). Here, SOX9 is linked to idiopathic pulmonary fibrosis.